Faron Pharmaceuticals Oy Stock Price, News & Analysis
Company Description
Faron Pharmaceuticals Oy (OTC: FPHAF) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $209.5M.
FPHAF stock has declined 13.6% over the past year.
This page provides a comprehensive overview of FPHAF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Faron Pharmaceuticals Oy (FPHAF) stock. Over the past 12 months, the stock has lost 13.6%. At a market capitalization of $209.5M, FPHAF is classified as a micro-cap stock with approximately 63.5M shares outstanding.
Latest News
Faron Pharmaceuticals Oy has 1 recent news article. View all FPHAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
FPHAF Company Profile & Sector Positioning
Faron Pharmaceuticals Oy (FPHAF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing FPHAF often look at related companies in the same sector, including Codexis Inc (CDXS), Cargo Therapeutics (CRGX), Aclaris Therapeutics Inc (ACRS), Genfit S.A. (GNFT), and Tiziana Life Sciences Ltd Com (TLSA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FPHAF's relative position within its industry.